Article
Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping.
Pharmacogenetics - 1 Jun 2001
Streetman D S, Kashuba A D, Bertino J S, Kulawy R, Rocci M L, Nafziger A N
Abstract excerpt
Midazolam (MDZ) total clearance (ClT) is widely used for cytochrome P450 3A (CYP3A) phenotyping, but requires up to eight blood samples. This study was conducted to compare the use of midazolam ClT to use of a midazolam urinary metabolic ratio for CYP3A phenotyping. Ten male and 10 female subjects received i.v. midazolam 0.025 mg/kg eight times over a 4-month period at approximately 2-week intervals. The first...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
